190 related articles for article (PubMed ID: 36273200)
1. Quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging to predict lymphovascular invasion and survival outcome in breast cancer.
Lai T; Chen X; Yang Z; Huang R; Liao Y; Chen X; Dai Z
Cancer Imaging; 2022 Oct; 22(1):61. PubMed ID: 36273200
[TBL] [Abstract][Full Text] [Related]
2. Value of quantitative dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging in predicting extramural venous invasion in locally advanced gastric cancer and prognostic significance.
Zhu Y; Zhou Y; Zhang W; Xue L; Li Y; Jiang J; Zhong Y; Wang S; Jiang L
Quant Imaging Med Surg; 2021 Jan; 11(1):328-340. PubMed ID: 33392032
[TBL] [Abstract][Full Text] [Related]
3. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Lymphovascular Invasion in Breast Cancer Using a Combined MRI Morphological Features, Radiomics, and Deep Learning Approach Based on Dynamic Contrast-Enhanced MRI.
Yang X; Fan X; Lin S; Zhou Y; Liu H; Wang X; Zuo Z; Zeng Y
J Magn Reson Imaging; 2024 Jun; 59(6):2238-2249. PubMed ID: 37855421
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Dynamic-Enhanced MRI and Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Prediction of the Pathological Response to Neoadjuvant Chemotherapy and the Prognosis in Locally Advanced Gastric Cancer.
Zhu Y; Jiang Z; Wang B; Li Y; Jiang J; Zhong Y; Wang S; Jiang L
Front Oncol; 2022; 12():841460. PubMed ID: 35425711
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
[TBL] [Abstract][Full Text] [Related]
7. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
[TBL] [Abstract][Full Text] [Related]
8. Using Machine Learning Methods to Assess Lymphovascular Invasion and Survival in Breast Cancer: Performance of Combining Preoperative Clinical and MRI Characteristics.
Xu Z; Xie Y; Wu L; Chen M; Shi Z; Cui Y; Han C; Lin H; Liu Y; Li P; Chen X; Ding Y; Liu Z
J Magn Reson Imaging; 2023 Nov; 58(5):1580-1589. PubMed ID: 36797654
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Lymphovascular invasion status in breast cancer based on magnetic resonance imaging radiomics features.
Li X; Luo K; Zhang N; Chen W; Li B; Lu Z; Chen Y; Wu K
Magn Reson Imaging; 2024 Jun; 109():91-95. PubMed ID: 38467265
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Dynamic Contrast-Enhanced and Diffusion-Weighted Breast Magnetic Resonance Imaging Findings for Prediction of Lymphovascular Invasion of the Lesions in Node-Negative Invasive Breast Cancer.
Coşkun Bilge A; Yaltırık Bilgin E; Bulut ZM; Esen Bostancı I; Bilgin E
Can Assoc Radiol J; 2024 May; 75(2):386-396. PubMed ID: 38095635
[No Abstract] [Full Text] [Related]
12. Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Jul; 97(30):e11647. PubMed ID: 30045313
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
14. Identification of triple-negative breast cancer and androgen receptor expression based on histogram and texture analysis of dynamic contrast-enhanced MRI.
Xu WJ; Zheng BJ; Lu J; Liu SY; Li HL
BMC Med Imaging; 2023 Jun; 23(1):70. PubMed ID: 37264313
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prediction of extramural venous invasion in rectal cancer by dynamic contrast-enhanced and diffusion weighted MRI: a preliminary study.
Ao W; Zhang X; Yao X; Zhu X; Deng S; Feng J
BMC Med Imaging; 2022 Apr; 22(1):78. PubMed ID: 35484509
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study.
Houvenaeghel G; Cohen M; Classe JM; Reyal F; Mazouni C; Chopin N; Martinez A; Daraï E; Coutant C; Colombo PE; Gimbergues P; Chauvet MP; Azuar AS; Rouzier R; Tunon de Lara C; Muracciole X; Agostini A; Bannier M; Charaffe Jauffret E; De Nonneville A; Goncalves A
ESMO Open; 2021 Dec; 6(6):100316. PubMed ID: 34864349
[TBL] [Abstract][Full Text] [Related]
18. Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary study.
Chen X; Yang Z; Yang J; Liao Y; Pang P; Fan W; Chen X
Cancer Imaging; 2020 Apr; 20(1):24. PubMed ID: 32248822
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a point-based scoring system for predicting axillary lymph node metastasis and disease outcome in breast cancer using clinicopathological and multiparametric MRI features.
Chen X; Yang Z; Huang R; Li Y; Liao Y; Li G; Wang M; Chen X; Dai Z; Fan W
Cancer Imaging; 2023 Jun; 23(1):54. PubMed ID: 37264446
[TBL] [Abstract][Full Text] [Related]
20. Quantitative dynamic contrast-enhanced MR imaging can be used to predict the pathologic stages of oral tongue squamous cell carcinoma.
Guo N; Zeng W; Deng H; Hu H; Cheng Z; Yang Z; Jiang S; Duan X; Shen J
BMC Med Imaging; 2020 Oct; 20(1):117. PubMed ID: 33066760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
